Literature DB >> 18023255

The challenge of being diagnosed and treated for ductal carcinoma in situ (DCIS).

Fiona Kennedy1, Diana Harcourt, Nichola Rumsey.   

Abstract

Following the introduction of the National Health Service Breast Screening Programme (NHSBSP) in the UK increasing numbers of women are diagnosed with ductal carcinoma in situ (DCIS). In DCIS, the cancer cells are confined to the ducts of the breast but considerable uncertainty surrounds the condition. Patients are often reassured that it is non-invasive and not life-threatening but they are recommended similar treatments to patients with invasive breast cancer. Little research has investigated the psychosocial impact of DCIS; therefore the aim of this qualitative study was to explore women's experiences of the condition. Semi-structured interviews were conducted with a purposive sample of 16 women previously diagnosed and treated for DCIS. Thematic analysis identified six key themes: (1) invisibility of DCIS, (2) uncertainty, (3) perceptions of DCIS, (4) acceptance of treatment, (5) social support and (6) moving on. The results highlight the substantial challenges faced by women diagnosed with DCIS. These findings have clear significance for healthcare professionals, especially specialist nurses, who work closely with DCIS patients.

Entities:  

Mesh:

Year:  2007        PMID: 18023255     DOI: 10.1016/j.ejon.2007.09.007

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  6 in total

1.  Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American Cancer Society and National Cancer Institute workshop.

Authors:  Ann H Partridge; Joann G Elmore; Debbie Saslow; Worta McCaskill-Stevens; Stuart J Schnitt
Journal:  CA Cancer J Clin       Date:  2012-04-04       Impact factor: 508.702

2.  Development and pilot testing of a communication aid to assist clinicians to communicate with women diagnosed with ductal carcinoma in situ (DCIS).

Authors:  Simone E De Morgan; Phyllis N Butow; Elizabeth A Lobb; Melanie A Price; Caroline Nehill
Journal:  Support Care Cancer       Date:  2010-11-19       Impact factor: 3.603

3.  "Is it cancer or not?" A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ.

Authors:  Shoshana M Rosenberg; Jennifer M Gierisch; Anna C Revette; Carol L Lowenstein; Elizabeth S Frank; Deborah E Collyar; Thomas Lynch; Alastair M Thompson; Ann H Partridge; E Shelley Hwang
Journal:  Cancer       Date:  2022-02-22       Impact factor: 6.921

4.  A Nationwide Cross-Sectional Survey of UK Breast Surgeons' Views on the Management of Ductal Carcinoma In Situ.

Authors:  Gurdeep S Mannu; Joao H Bettencourt-Silva; Farid Ahmed; Giles Cunnick
Journal:  Int J Breast Cancer       Date:  2015-11-30

5.  Patient Uncertainty Questionnaire-Rheumatology (PUQ-R): development and validation of a new patient-reported outcome instrument for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in a mixed methods study.

Authors:  Sophie Cleanthous; David Alan Isenberg; Stanton Peter Newman; Stefan John Cano
Journal:  Health Qual Life Outcomes       Date:  2016-03-01       Impact factor: 3.186

Review 6.  Interventions are needed to support patient-provider decision-making for DCIS: a scoping review.

Authors:  Claire Kim; Laurel Liang; Frances C Wright; Nicole J Look Hong; Gary Groot; Lucy Helyer; Pamela Meiers; May Lynn Quan; Robin Urquhart; Rebecca Warburton; Anna R Gagliardi
Journal:  Breast Cancer Res Treat       Date:  2017-12-23       Impact factor: 4.872

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.